EICHORCondition: Eosinophilic Esophagitis · Sponsor: Phathom Pharmaceuticals, Inc.
The primary objective of this study is to assess the efficacy of vonoprazan 20 mg once daily (QD) compared to placebo QD in the number of participants with a peak eosinophilic histologic response \<15 eosinophils per high-power field (eos/hpf) after 12 weeks of therapy.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Preferred Research Partners, Inc | Little Rock, Arkansas, United States | — |
| GW Research, Inc | Chula Vista, California, United States | — |
| Southern California Research Institute Medical Group | Los Angeles, California, United States | — |
| Rocky Mountain Gastroenterology | Lakewood, Colorado, United States | — |
| Western States Clinical Research, Inc. | Wheat Ridge, Colorado, United States | — |
| Connecticut Clinical Research Institute | Bristol, Connecticut, United States | — |
| Nature Coast Clinical Research | Inverness, Florida, United States | — |
| Encore Borland-Groover Clinical Research | Jacksonville, Florida, United States | — |
| International Center for Research | Tampa, Florida, United States | — |
| Gastroenterology Associates of Central Georgia, LLC | Macon, Georgia, United States | — |
| Treasure Valley Medical Research | Boise, Idaho, United States | — |
| Grand Teton Research Group | Idaho Falls, Idaho, United States | — |
+ 29 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06851559